Laddar...
Comparative antibacterial activity of a new oral cephalosporin, BMY-28100.
BMY-28100 is a new oral cephalosporin which had in vitro activity superior to that of cephalexin and cefaclor against staphylococci, beta-hemolytic streptococcal species, and Streptococcus pneumoniae. It inhibited beta-lactamase-producing Haemophilus influenzae, Neisseria gonorrhoeae, 50% of Strepto...
Sparad:
| Huvudupphovsmän: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
1987
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC174759/ https://ncbi.nlm.nih.gov/pubmed/3495236 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|